This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Gentex (GNTX) delivered earnings and revenue surprises of 2.94% and 0.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Westport Fuel, Adient, Lithia, Sonic Automotive, and Daimler
Auto Stock Roundup: WPRT & ADNT Quarterly Results, DDAIF Twin Deals & More
by Rimmi Singhi
While Westport (WPRT) and Adient (ADNT) deliver quarterly losses, Daimler (DDAIF) collaborates with Total Energies and Visa.
Adient's (ADNT) Q4 Loss Narrower Than Expected, Sales Miss
by Zacks Equity Research
Adient (ADNT) expects fiscal 2022 revenues of $14.8 billion, higher than $13.7 billion recorded in fiscal 2021.
Key Factors to Note Ahead of Hyliion's (HYLN) Q3 Earnings
by Zacks Equity Research
Rising R&D and SG&A expenses are likely to have dented Hyliion's (HYLN) Q3 performance.
Lear's (LEA) Q3 Earnings Miss Estimates, 2021 View Tepid
by Zacks Equity Research
Lear (LEA) forecasts full-year 2021 sales in the band of $18.8-$19.2 billion, down from the previous guided range of $20.3-$21.1 billion.
Analysts Estimate Adient (ADNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Factors to Note Ahead of Magna's (MGA) Q3 Earnings
by Zacks Equity Research
Declining revenues across all segments and rising costs are likely to have dented Magna's (MGA) Q3 performance.
Oshkosh (OSK) Beats Q4 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Oshkosh (OSK) delivers a comprehensive fiscal Q4 beat and announces a 12% dividend hike.
Allison (ALSN) Q3 Earnings Match Estimates, Sales Beat
by Zacks Equity Research
Amid persistent supply chain disruptions, Allison (ALSN) trims its 2021 guidance. It now projects net sales in the band of $2,325-$2,400 million versus the prior estimate of $2,325-$2,475 million.
Gentex (GNTX) Lags Q3 Earnings & Sales Estimates, Revises 2H'21 View
by Zacks Equity Research
Gentex (GNTX) envisions net sales in the band of $770-$840 million for second-half 2021, lower than the previous outlook of $970 million-$1.07 billion.
New Strong Sell Stocks for October 11th
by Zacks Equity Research
ADNT, MOMO, LEA, PLUG and TEN have been added to the Zacks Rank #5 (Strong Sell) List on October 11, 2021.
Adient (ADNT) Down 2.5% Since Q3 Loss, Slashes FY21 View
by Zacks Equity Research
Adient (ADNT) projects fiscal 2021 revenues within $14.3-$14.5 billion, lower than the prior outlook of $14.6-$15 billion.
Magna (MGA) Q2 Earnings & Sales Miss Mark, Trims '21 View
by Zacks Equity Research
Magna (MGA) downwardly revises 2021 outlook amid chip crunch. It now expects revenues in the band of $38-$39.5 billion, down from the previous view of $40.2-$41.8 billion.
Allison (ALSN) Down 2.8% Since Q2 Earnings & Sales Beat
by Zacks Equity Research
Allison Transmission (ALSN) projects adjusted free cash flow within $415-$475 million for 2021.
LEAR (LEA) Q2 Earnings Beat, Sales Miss Estimates, '21 View Down
by Zacks Equity Research
For 2021, Lear (LEA) projects net sales of $19.7-$20.5 billion, lower than the earlier forecast of $20.3-$21.1 billion.
Meritor (MTOR) Beats on Q3 Earnings & Sales, Revises FY21 View
by Zacks Equity Research
Meritor (MTOR) projects sales at $3.9 billion for fiscal 2021, up from the previous forecast of $3.65-$3.8 billion.
Adient (ADNT) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -762.50% and 1.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Oshkosh (OSK) Stock Down Since Q3 Earnings & Revenue Miss
by Zacks Equity Research
Oshkosh (OSK) expects fiscal 2021 adjusted EPS in the band of $6.35-$6.50 compared with the prior view of $6.35-$6.85.
Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gentex (GNTX) Q2 Earnings & Sales Miss Mark, 2H'21 View Dull
by Zacks Equity Research
Gentex (GNTX) anticipates lower light vehicle production, and high commodity, freight and labor expenses to weigh on the firm's earnings as well as sales for second-half 2021.
ETF & Stocks to Ride on Auto Industry Strength
by Sweta Killa
The U.S. auto industry has been showing strength as the economy reopens and more people shift to private conveyance due to the COVID-19 pandemic.
Zacks.com featured highlights include: Macy's, Adient, Imperial Oil, Ryder System and The Chemours Co
by Zacks Equity Research
Zacks.com featured highlights include: Macy's, Adient, Imperial Oil, Ryder System and The Chemours Co
5 Top-Ranked Stocks Displaying High Earnings Yield
by Rimmi Singhi
Earnings yield is an important tool for investors with exposure to both stocks and bonds.